Entity
  • Paris Saclay Cancer Cluster (PSCC)

    Created in 2022
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    7,109
  • Activities

  • Entity types

  • Location

    94800 Villejuif, France

    Villejuif

    France

  • Employees

    Scale: 2-10

    Estimated: 20

  • Engaged corporates

    36
    13 29
  • Added in Motherbase

    1 year, 8 months ago
Description
  • Value proposition

    Bringing together the actors of oncology innovation to develop solutions in France for the patients.

    As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient.

    🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories.

    🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation centers, is the largest in Europe, with nearly 80 members and 9 nationalities.

    💡 Created in February 2022 at the initiative of the Paris-Saclay University, the Polytechnic Institute of Paris, Inserm, the Gustave Roussy Institute and Sanofi, the PSCC is a continuum of excellence, bringing together research organizations, universities, hospitals, start-ups, scale-ups, industrialists, capital investors, patient associations, government, local authorities, and stakeholders.

    Chaired by Professors Eric Vivier and Solange Peters, the association and its Strategic Advisory Board reflect the cluster's twofold ambition: to change the destiny of millions of patients and to position France and Europe at the forefront of the world's leading pharmaceutical industry.


    oncologie, Cancer, Innovation, and Oncocluster

  • Original language

    Bringing together the actors of oncology innovation to develop solutions in France for the patients.

    As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient.

    🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories.

    🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation centers, is the largest in Europe, with nearly 80 members and 9 nationalities.

    💡 Created in February 2022 at the initiative of the Paris-Saclay University, the Polytechnic Institute of Paris, Inserm, the Gustave Roussy Institute and Sanofi, the PSCC is a continuum of excellence, bringing together research organizations, universities, hospitals, start-ups, scale-ups, industrialists, capital investors, patient associations, government, local authorities, and stakeholders.

    Chaired by Professors Eric Vivier and Solange Peters, the association and its Strategic Advisory Board reflect the cluster's twofold ambition: to change the destiny of millions of patients and to position France and Europe at the forefront of the world's leading pharmaceutical industry.

  • Biocluster | Paris-saclay Cancer Cluster

    Le Paris Saclay Cancer Cluster est avant tout un lieu de convergence des acteurs pluridisciplinaires travaillant tous pour la lutte contre le cancer.

  • https://www.parissaclaycancercluster.org/
Corporate interactions BETA
Corporate TypeTweets Articles
Astellas Pharma
Astellas Pharma
Pharmaceutical
Astellas Pharma
Pharmaceutical
Other

2 Oct 2024


Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services
Other

1 Oct 2024


Technofounders
Technofounders
Research, Research Services
Technofounders
Research, Research Services
Other

1 Oct 2024


Kurma Partners
Kurma Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Kurma Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

1 Oct 2024


Elaia
Elaia
Startup accelerator & VC, Venture Capital and Private Equity Principals
Elaia
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

1 Oct 2024


Linksium
Linksium
Venture Capital and Private Equity Principals
Linksium
Venture Capital and Private Equity Principals
Other

24 Sep 2024


Seventure Partners
Seventure Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Seventure Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

22 Aug 2024


Edmond de Rothschild Edmond de Rothschild
Other

22 Jun 2024


Business France
Business France
National and local authorities, Government Administration
Business France
National and local authorities, Government Administration
Other

21 Jun 2024


Ipsen
Ipsen
Pharmaceutical, Pharmaceutical Manufacturing
Ipsen
Pharmaceutical, Pharmaceutical Manufacturing
Other

22 Jun 2024


Similar entities
Loading...
Loading...
Social network dynamics